Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Novo Nordisk A/S NVO

Set alert

Price alert · NVO

All alert types
40.45 USD +0.45 +1.13%

At close

40.15 -0.30 -0.74%

Pre-market · Nov 3, 5:10 AM ET

Bid
40.45 × 1,100
Ask
40.46 × 2,100
40.06 Day range 40.78
35.12 52-week range 64.16
YTD
-20.50%
1 year
-18.22%
Open
40.10
Prev close
40.00
Mkt cap
178.41B
Vol
11.18M
Avg vol
12.69M
EPS
4.09
P/E
9.89
Div yield
4.49%
More statistics
Low
40.06
High
40.78
Forward P/E
11.76
Beta
0.37
Short ratio
2.52
Inst. own
9.83%
Dividend
1.80
Ex-div date
Aug 16, 2026
Earnings
Nov 4, 2026
50-d avg
41.23
200-d avg
44.19
1y target
45.09

5D chart

Chart tools
Interval
1m5m15m30m

Signals (94)
NameTimeAgo
MACD: Sell SignalNov 2, 3:45 PM13 hours ago
SMA: BearishNov 2, 3:40 PM13 hours ago
MACD: Buy SignalNov 2, 3:20 PM13 hours ago
SMA: BullishNov 2, 2:55 PM14 hours ago
SMA: BearishNov 2, 2:15 PM14 hours ago
SMA: BullishNov 2, 12:50 PM16 hours ago
SMA: BearishNov 2, 12:40 PM16 hours ago
MACD: Sell SignalNov 2, 11:25 AM17 hours ago
RSI: OverboughtNov 2, 11:05 AM18 hours ago
SMA: BullishNov 2, 10:25 AM18 hours ago
SMA: BearishNov 2, 10:10 AM19 hours ago
RSI: OverboughtNov 2, 9:30 AM19 hours ago
MACD: Buy SignalOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 3:50 PM3 days ago
SMA: BullishOct 30, 3:50 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
SMA: BullishOct 30, 3:10 PM3 days ago
SMA: BearishOct 30, 3:00 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 2:45 PM3 days ago

Newest 20 of 94.

Analyst view

Consensus: hold

Hold
Price target (mean) 45.09 +11.5% upside
Target (low)
39.75
Target (mean)
45.09
Target (high)
61.79
Ratings (0m) 14 3 buy · 10 hold · 1 sell
  • Strong buy0
  • Buy3
  • Hold10
  • Sell1
  • Strong sell0

Recommendation trend

  • This month 14
  • 1 month ago 14
  • 2 months ago 14

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NVO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter4.624.01 – 5.284.50+2.7%73.79B-1.6%3
Next quarter4.314.26 – 4.366.04-28.7%76.23B-3.7%2
Current year22.3921.01 – 24.2523.03-2.8%303.54B-1.8%8
Next year22.8921.73 – 23.7422.39+2.3%307.63B+1.4%7

Upgrades and downgrades

The latest rating changes

NVO analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026BMO CapitalMaintainedMarket PerformMarket Perform
Sep 11, 2026Morgan StanleyDowngradeEqual-WeightUnderweight
Mar 2, 2026Goldman SachsDowngradeBuyNeutral
Feb 24, 2026JP MorganDowngradeOverweightNeutral
Jan 9, 2026CICCInitiated—Outperform
Dec 8, 2025Argus ResearchDowngradeBuyHold
Nov 28, 2025Goldman SachsMaintainedBuyBuy
Nov 25, 2025BMO CapitalMaintainedMarket PerformMarket Perform
Nov 24, 2025HSBCDowngradeBuyHold
Oct 14, 2025BMO CapitalMaintainedMarket PerformMarket Perform
Oct 2, 2025HSBCUpgradeHoldBuy
Sep 29, 2025Morgan StanleyDowngradeEqual-WeightUnderweight
Sep 17, 2025BerenbergUpgradeHoldBuy
Aug 19, 2025TD CowenMaintainedBuyBuy
Aug 5, 2025UBSDowngradeBuyNeutral
Jul 31, 2025HSBCDowngradeBuyHold
Jul 30, 2025BarclaysDowngradeOverweightEqual-Weight
Jun 18, 2025TD CowenReiteratedBuyBuy
Apr 17, 2025BMO CapitalDowngradeOutperformMarket Perform
Jan 8, 2025UBSUpgradeSellBuy
Dec 23, 2024BMO CapitalMaintainedOutperformOutperform
Nov 6, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Oct 22, 2024CitigroupMaintainedBuyBuy
Oct 17, 2024BMO CapitalMaintainedOutperformOutperform
Oct 16, 2024BarclaysMaintainedOverweightOverweight
Oct 14, 2024BMO CapitalMaintainedMarket PerformMarket Perform
Oct 10, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Oct 10, 2024JefferiesInitiated—Buy
Sep 20, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Sep 16, 2024Cantor FitzgeraldReiteratedOverweightOverweight